A 0 1 0 1 O
malignancy 2 12 2 12 B-cancer
that 13 17 13 17 O
was 18 21 18 21 O
treated 22 29 22 29 O
with 30 34 30 34 O
curative 35 43 35 43 B-treatment
intent 44 50 44 50 I-treatment
, 50 51 50 51 O
for 52 55 52 55 O
which 56 61 56 61 O
there 62 67 62 67 O
has 68 71 68 71 O
been 72 76 72 76 O
no 77 79 77 79 O
known 80 85 80 85 O
active 86 92 86 92 O
disease 93 100 93 100 O
for 101 104 101 104 O
> 105 106 105 106 O
3 106 107 106 107 B-lower_bound
years 108 113 108 113 I-lower_bound
prior 114 119 114 119 I-lower_bound
to 120 122 120 122 O
randomization 123 136 123 136 O
, 136 137 136 137 O
and 138 141 138 141 O
for 142 145 142 145 O
which 146 151 146 151 O
the 152 155 152 155 O
risk 156 160 156 160 O
of 161 163 161 163 O
recurrence 164 174 164 174 O
is 175 177 175 177 O
low 178 181 178 181 O
as 182 184 182 184 O
determined 185 195 185 195 O
by 196 198 196 198 O
the 199 202 199 202 O
investigator 203 215 203 215 O

Age 0 3 216 219 B-age
≥18 4 7 220 223 O
years 8 13 224 229 I-lower_bound

Any 0 3 230 233 O
uncontrolled 4 16 234 246 O
intercurrent 17 29 247 259 B-chronic_disease
illness 30 37 260 267 I-chronic_disease
including 38 47 268 277 O
, 47 48 277 278 O
but 49 52 279 282 O
not 53 56 283 286 O
limited 57 64 287 294 O
to 65 67 295 297 O
, 67 68 297 298 O
ongoing 69 76 299 306 O
or 77 79 307 309 O
active 80 86 310 316 B-chronic_disease
infection 87 96 317 326 I-chronic_disease
, 96 97 326 327 O
symptomatic 98 109 328 339 O
congestive 110 120 340 350 B-chronic_disease
heart 121 126 351 356 I-chronic_disease
failure 127 134 357 364 I-chronic_disease
, 134 135 364 365 O
unstable 136 144 366 374 B-chronic_disease
angina 145 151 375 381 I-chronic_disease
pectoris 152 160 382 390 I-chronic_disease
, 160 161 390 391 O
cardiac 162 169 392 399 B-chronic_disease
arrhythmia 170 180 400 410 I-chronic_disease
, 180 181 410 411 O
or 182 184 412 414 O
psychiatric 185 196 415 426 B-chronic_disease
illness 197 204 427 434 I-chronic_disease
/ 204 205 434 435 O
social 205 211 435 441 B-chronic_disease
situations 212 222 442 452 I-chronic_disease
that 223 227 453 457 O
, 227 228 457 458 O
in 229 231 459 461 O
the 232 235 462 465 O
opinion 236 243 466 473 O
of 244 246 474 476 O
the 247 250 477 480 O
investigator 251 263 481 493 O
, 263 264 493 494 O
may 265 268 495 498 O
increase 269 277 499 507 O
the 278 281 508 511 O
risks 282 287 512 517 O
associated 288 298 518 528 O
with 299 303 529 533 O
study 304 309 534 539 O
participation 310 323 540 553 O
or 324 326 554 556 O
study 327 332 557 562 O
treatment 333 342 563 572 B-treatment
, 342 343 572 573 O
limit 344 349 574 579 O
compliance 350 360 580 590 O
with 361 365 591 595 O
study 366 371 596 601 O
requirements 372 384 602 614 O
, 384 385 614 615 O
or 386 388 616 618 O
interfere 389 398 619 628 O
with 399 403 629 633 O
the 404 407 634 637 O
interpretation 408 422 638 652 O
of 423 425 653 655 O
study 426 431 656 661 O
results 432 439 662 669 O

Concurrent 0 10 670 680 O
use 11 14 681 684 O
of 15 17 685 687 O
other 18 23 688 693 O
anti 24 28 694 698 B-treatment
- 28 29 698 699 I-treatment
cancer 29 35 699 705 I-treatment
therapy 36 43 706 713 I-treatment
, 43 44 713 714 O
including 45 54 715 724 O
chemotherapy 55 67 725 737 B-treatment
agents 68 74 738 744 I-treatment
, 74 75 744 745 O
targeted 76 84 746 754 B-treatment
agents 85 91 755 761 I-treatment
, 91 92 761 762 O
biological 93 103 763 773 B-treatment
agents 104 110 774 780 I-treatment
, 110 111 780 781 O
immunotherapy 112 125 782 795 B-treatment
, 125 126 795 796 O
or 127 129 797 799 O
investigational 130 145 800 815 B-treatment
agents 146 152 816 822 I-treatment
not 153 156 823 826 O
otherwise 157 166 827 836 O
specified 167 176 837 846 O
in 177 179 847 849 O
this 180 184 850 854 O
protocol 185 193 855 863 O

Curatively 0 10 864 874 O
treated 11 18 875 882 O
non 19 22 883 886 B-cancer
- 22 23 886 887 I-cancer
melanoma 23 31 887 895 I-cancer
skin 32 36 896 900 I-cancer
malignancy 37 47 901 911 I-cancer
, 47 48 911 912 O
cervical 49 57 913 921 B-cancer
cancer 58 64 922 928 I-cancer
in 65 67 929 931 I-cancer
situ 68 72 932 936 I-cancer
, 72 73 936 937 O
or 74 76 938 940 O
prostatic 77 86 941 950 B-cancer
intraepithelial 87 102 951 966 I-cancer
neoplasia 103 112 967 976 I-cancer
without 113 120 977 984 O
evidence 121 129 985 993 O
of 130 132 994 996 O
prostate 133 141 997 1005 B-cancer
cancer 142 148 1006 1012 I-cancer

ECOG 0 4 1013 1017 B-clinical_variable
performance 5 16 1018 1029 I-clinical_variable
status 17 23 1030 1036 I-clinical_variable
≤ 24 25 1037 1038 O
1 26 27 1039 1040 B-upper_bound

History 0 7 1041 1048 O
of 8 10 1049 1051 O
allergic 11 19 1052 1060 O
reactions 20 29 1061 1070 O
attributed 30 40 1071 1081 O
to 41 43 1082 1084 O
compounds 44 53 1085 1094 O
of 54 56 1095 1097 O
similar 57 64 1098 1105 O
chemical 65 73 1106 1114 O
or 74 76 1115 1117 O
biologic 77 85 1118 1126 O
composition 86 97 1127 1138 O
to 98 100 1139 1141 O
vitamin 101 108 1142 1149 B-allergy_name
D 109 110 1150 1151 I-allergy_name

History 0 7 1152 1159 O
of 8 10 1160 1162 O
malabsorption 11 24 1163 1176 B-chronic_disease
or 25 27 1177 1179 O
uncontrolled 28 40 1180 1192 O
vomiting 41 49 1193 1201 B-chronic_disease
or 50 52 1202 1204 O
diarrhea 53 61 1205 1213 B-chronic_disease
, 61 62 1213 1214 O
or 63 65 1215 1217 O
any 66 69 1218 1221 O
other 70 75 1222 1227 O
disease 76 83 1228 1235 O
significantly 84 97 1236 1249 O
affecting 98 107 1250 1259 O
gastrointestinal 108 124 1260 1276 O
function 125 133 1277 1285 O
that 134 138 1286 1290 O
could 139 144 1291 1296 O
interfere 145 154 1297 1306 O
with 155 159 1307 1311 O
absorption 160 170 1312 1322 O
of 171 173 1323 1325 O
oral 174 178 1326 1330 B-treatment
medications 179 190 1331 1342 I-treatment

History 0 7 1343 1350 O
of 8 10 1351 1353 O
prior 11 16 1354 1359 O
or 17 19 1360 1362 O
synchronous 20 31 1363 1374 B-cancer
malignancy 32 42 1375 1385 I-cancer

History 0 7 1386 1393 O
of 8 10 1394 1396 O
symptomatic 11 22 1397 1408 O
genitourinary 23 36 1409 1422 B-chronic_disease
stones 37 43 1423 1429 I-chronic_disease
within 44 50 1430 1436 O
the 51 54 1437 1440 O
past 55 59 1441 1445 O
year 60 64 1446 1450 O

Known 0 5 1451 1456 O
active 6 12 1457 1463 O
hyperparathyroid 13 29 1464 1480 B-chronic_disease
disease 30 37 1481 1488 I-chronic_disease
or 38 40 1489 1491 O
other 41 46 1492 1497 O
serious 47 54 1498 1505 O
disturbance 55 66 1506 1517 O
of 67 69 1518 1520 O
calcium 70 77 1521 1528 O
metabolism 78 88 1529 1539 O
in 89 91 1540 1542 O
the 92 95 1543 1546 O
past 96 100 1547 1551 B-upper_bound
5 101 102 1552 1553 I-upper_bound
years 103 108 1554 1559 I-upper_bound

Known 0 5 1560 1565 O
positive 6 14 1566 1574 O
test 15 19 1575 1579 O
for 20 23 1580 1583 O
human 24 29 1584 1589 B-chronic_disease
immunodeficiency 30 46 1590 1606 I-chronic_disease
virus 47 52 1607 1612 I-chronic_disease
( 53 54 1613 1614 I-chronic_disease
HIV 54 57 1614 1617 I-chronic_disease
) 57 58 1617 1618 I-chronic_disease
, 58 59 1618 1619 O
hepatitis 60 69 1620 1629 B-chronic_disease
C 70 71 1630 1631 I-chronic_disease
virus 72 77 1632 1637 I-chronic_disease
, 77 78 1637 1638 O
or 79 81 1639 1641 O
acute 82 87 1642 1647 O
or 88 90 1648 1650 O
chronic 91 98 1651 1658 B-chronic_disease
hepatitis 99 108 1659 1668 I-chronic_disease
B 109 110 1669 1670 I-chronic_disease
infection 111 120 1671 1680 I-chronic_disease

No 0 2 1681 1683 O
prior 3 8 1684 1689 B-treatment
radiation 9 18 1690 1699 I-treatment
therapy 19 26 1700 1707 I-treatment
or 27 29 1708 1710 O
systemic 30 38 1711 1719 B-treatment
treatment 39 48 1720 1729 I-treatment
is 49 51 1730 1732 O
allowed 52 59 1733 1740 O
for 60 63 1741 1744 O
patients 64 72 1745 1753 O
undergoing 73 83 1754 1764 O
resection 84 93 1765 1774 O
of 94 96 1775 1777 O
stage 97 102 1778 1783 B-cancer
I 103 104 1784 1785 I-cancer
, 104 105 1785 1786 O
II 106 108 1787 1789 B-cancer
, 108 109 1789 1790 O
or 110 112 1791 1793 O
III 113 116 1794 1797 B-cancer
colon 117 122 1798 1803 I-cancer
cancer 123 129 1804 1810 I-cancer

Non 0 3 1811 1814 B-pregnancy
- 3 4 1814 1815 I-pregnancy
pregnant 4 12 1815 1823 I-pregnancy

Participants 0 12 1824 1836 O
must 13 17 1837 1841 O
have 18 22 1842 1846 O
histologically 23 37 1847 1861 O
confirmed 38 47 1862 1871 O
adenocarcinoma 48 62 1872 1886 B-cancer
of 63 65 1887 1889 I-cancer
the 66 69 1890 1893 I-cancer
colon 70 75 1894 1899 I-cancer
that 76 80 1900 1904 O
is 81 83 1905 1907 O
localized 84 93 1908 1917 O
, 93 94 1917 1918 O
with 95 99 1919 1923 O
no 100 102 1924 1926 O
evidence 103 111 1927 1935 O
of 112 114 1936 1938 O
distant 115 122 1939 1946 B-cancer
metastasis 123 133 1947 1957 I-cancer
( 134 135 1958 1959 O
stage 135 140 1959 1964 B-lower_bound
I 141 142 1965 1966 I-lower_bound
, 142 143 1966 1967 O
II 144 146 1968 1970 O
, 146 147 1970 1971 O
or 148 150 1972 1974 O
III 151 154 1975 1978 B-upper_bound
) 154 155 1978 1979 O
, 155 156 1979 1980 O
and 157 160 1981 1984 O
for 161 164 1985 1988 O
which 165 170 1989 1994 O
surgical 171 179 1995 2003 B-treatment
resection 180 189 2004 2013 I-treatment
of 190 192 2014 2016 I-treatment
the 193 196 2017 2020 I-treatment
primary 197 204 2021 2028 I-treatment
tumor 205 210 2029 2034 I-treatment
is 211 213 2035 2037 O
being 214 219 2038 2043 O
planned 220 227 2044 2051 O

Participants 0 12 2052 2064 O
must 13 17 2065 2069 O
have 18 22 2070 2074 O
histologically 23 37 2075 2089 O
or 38 40 2090 2092 O
cytologically 41 54 2093 2106 O
confirmed 55 64 2107 2116 O
adenocarcinoma 65 79 2117 2131 B-cancer
of 80 82 2132 2134 I-cancer
the 83 86 2135 2138 I-cancer
colon 87 92 2139 2144 I-cancer
with 93 97 2145 2149 O
resectable 98 108 2150 2160 O
liver 109 114 2161 2166 B-cancer
metastases 115 125 2167 2177 I-cancer
for 126 129 2178 2181 O
which 130 135 2182 2187 O
liver 136 141 2188 2193 B-treatment
resection 142 151 2194 2203 I-treatment
is 152 154 2204 2206 O
being 155 160 2207 2212 O
planned 161 168 2213 2220 O

Participants 0 12 2221 2233 O
who 13 16 2234 2237 O
have 17 21 2238 2242 O
had 22 25 2243 2246 O
chemotherapy 26 38 2247 2259 B-treatment
or 39 41 2260 2262 O
radiotherapy 42 54 2263 2275 B-treatment
within 55 61 2276 2282 O
4 62 63 2283 2284 B-upper_bound
weeks 64 69 2285 2290 I-upper_bound
( 70 71 2291 2292 O
6 71 72 2292 2293 B-upper_bound
weeks 73 78 2294 2299 I-upper_bound
for 79 82 2300 2303 O
bevacizumab 83 94 2304 2315 B-treatment
) 94 95 2315 2316 O
of 96 98 2317 2319 O
liver 99 104 2320 2325 B-treatment
resection 105 114 2326 2335 I-treatment

Participants 0 12 2336 2348 O
with 13 17 2349 2353 O
these 18 23 2354 2359 O
infections 24 34 2360 2370 B-chronic_disease
are 35 38 2371 2374 O
ineligible 39 49 2375 2385 O
because 50 57 2386 2393 O
they 58 62 2394 2398 O
are 63 66 2399 2402 O
at 67 69 2403 2405 O
increased 70 79 2406 2415 O
risk 80 84 2416 2420 O
of 85 87 2421 2423 O
significant 88 99 2424 2435 O
complications 100 113 2436 2449 O
in 114 116 2450 2452 O
the 117 120 2453 2456 O
perioperative 121 134 2457 2470 O
period 135 141 2471 2477 O
, 141 142 2477 2478 O
particularly 143 155 2479 2491 O
for 156 159 2492 2495 O
active 160 166 2496 2502 O
hepatitis 167 176 2503 2512 B-chronic_disease
B 177 178 2513 2514 I-chronic_disease
or 179 181 2515 2517 O
C 182 183 2518 2519 B-chronic_disease
patients 184 192 2520 2528 O
undergoing 193 203 2529 2539 O
liver 204 209 2540 2545 B-treatment
resection 210 219 2546 2555 I-treatment

Pre 0 3 2556 2559 O
- 3 4 2559 2560 O
existing 4 12 2560 2568 O
hypercalcemia 13 26 2569 2582 B-chronic_disease
( 27 28 2583 2584 O
defined 28 35 2584 2591 O
as 36 38 2592 2594 O
baseline 39 47 2595 2603 B-clinical_variable
serum 48 53 2604 2609 I-clinical_variable
calcium 54 61 2610 2617 I-clinical_variable
above 62 67 2618 2623 O
the 68 71 2624 2627 O
institutional 72 85 2628 2641 O
ULN 86 89 2642 2645 O
, 89 90 2645 2646 O
corrected 91 100 2647 2656 O
for 101 104 2657 2660 O
albumin 105 112 2661 2668 B-clinical_variable
level 113 118 2669 2674 I-clinical_variable
if 119 121 2675 2677 O
albumin 122 129 2678 2685 O
is 130 132 2686 2688 O
not 133 136 2689 2692 O
within 137 143 2693 2699 O
institutional 144 157 2700 2713 O
limits 158 164 2714 2720 O
of 165 167 2721 2723 O
normal 168 174 2724 2730 O
) 174 175 2730 2731 O

Pregnant 0 8 2732 2740 B-pregnancy

Pregnant 0 8 2741 2749 B-pregnancy
and 9 12 2750 2753 O
nursing 13 20 2754 2761 O
women 21 26 2762 2767 B-gender
are 27 30 2768 2771 O
excluded 31 39 2772 2780 O
from 40 44 2781 2785 O
this 45 49 2786 2790 O
study 50 55 2791 2796 O
because 56 63 2797 2804 O
there 64 69 2805 2810 O
is 70 72 2811 2813 O
an 73 75 2814 2816 O
unknown 76 83 2817 2824 O
but 84 87 2825 2828 O
potential 88 97 2829 2838 O
risk 98 102 2839 2843 O
of 103 105 2844 2846 O
adverse 106 113 2847 2854 O
events 114 120 2855 2861 O
related 121 128 2862 2869 O
to 129 131 2870 2872 O
higher 132 138 2873 2879 O
- 138 139 2879 2880 O
dose 139 143 2880 2884 O
vitamin 144 151 2885 2892 B-treatment
D3 152 154 2893 2895 I-treatment
and 155 158 2896 2899 O
colon 159 164 2900 2905 O
or 165 167 2906 2908 O
liver 168 173 2909 2914 B-treatment
surgery 174 181 2915 2922 I-treatment
( 182 183 2923 2924 O
and 183 186 2924 2927 O
associated 187 197 2928 2938 O
perioperative 198 211 2939 2952 B-treatment
medications 212 223 2953 2964 I-treatment
and 224 227 2965 2968 O
anesthesia 228 238 2969 2979 O
) 238 239 2979 2980 O
on 240 242 2981 2983 O
the 243 246 2984 2987 O
human 247 252 2988 2993 O
fetus 253 258 2994 2999 O

Prior 0 5 3000 3005 B-treatment
systemic 6 14 3006 3014 I-treatment
therapy 15 22 3015 3022 I-treatment
, 22 23 3022 3023 O
radiotherapy 24 36 3024 3036 B-treatment
, 36 37 3036 3037 O
or 38 40 3038 3040 O
investigational 41 56 3041 3056 B-treatment
agent 57 62 3057 3062 I-treatment
in 63 65 3063 3065 O
participants 66 78 3066 3078 O
undergoing 79 89 3079 3089 O
surgery 90 97 3090 3097 B-treatment
for 98 101 3098 3101 O
stage 102 107 3102 3107 B-lower_bound
I 108 109 3108 3109 I-lower_bound
, 109 110 3109 3110 O
II 111 113 3111 3113 O
, 113 114 3113 3114 O
or 115 117 3115 3117 O
III 118 121 3118 3121 B-upper_bound
colon 122 127 3122 3127 B-cancer
cancer 128 134 3128 3134 I-cancer

Prior 0 5 3135 3140 O
systemic 6 14 3141 3149 O
treatment 15 24 3150 3159 B-treatment
or 25 27 3160 3162 O
radiation 28 37 3163 3172 B-treatment
therapy 38 45 3173 3180 I-treatment
is 46 48 3181 3183 O
allowed 49 56 3184 3191 O
for 57 60 3192 3195 O
patients 61 69 3196 3204 O
with 70 74 3205 3209 O
resectable 75 85 3210 3220 O
liver 86 91 3221 3226 B-cancer
metastases 92 102 3227 3237 I-cancer

Regular 0 7 3238 3245 O
use 8 11 3246 3249 O
of 12 14 3250 3252 O
supplemental 15 27 3253 3265 O
vitamin 28 35 3266 3273 B-treatment
D 36 37 3274 3275 I-treatment
totaling 38 46 3276 3284 O
≥ 47 48 3285 3286 O
2,000 49 54 3287 3292 B-lower_bound
IU 55 57 3293 3295 I-lower_bound
/ 57 58 3295 3296 I-lower_bound
day 58 61 3296 3299 I-lower_bound
in 62 64 3300 3302 O
the 65 68 3303 3306 O
past 69 73 3307 3311 B-lower_bound
year 74 78 3312 3316 I-lower_bound

Regular 0 7 3317 3324 O
use 8 11 3325 3328 O
of 12 14 3329 3331 O
thiazide 15 23 3332 3340 B-treatment
diuretics 24 33 3341 3350 I-treatment
( 34 35 3351 3352 O
i.e. 35 39 3352 3356 O
, 39 40 3356 3357 O
hydrochlorothiazide 41 60 3358 3377 B-treatment
) 60 61 3377 3378 O
, 61 62 3378 3379 O
which 63 68 3380 3385 O
can 69 72 3386 3389 O
lead 73 77 3390 3394 O
to 78 80 3395 3397 O
hypercalcemia 81 94 3398 3411 B-chronic_disease
, 94 95 3411 3412 O
and 96 99 3413 3416 O
unwillingness 100 113 3417 3430 O
or 114 116 3431 3433 O
inability 117 126 3434 3443 O
to 127 129 3444 3446 O
discontinue 130 141 3447 3458 O
or 142 144 3459 3461 O
switch 145 151 3462 3468 O
to 152 154 3469 3471 O
an 155 157 3472 3474 O
alternative 158 169 3475 3486 O
anti 170 174 3487 3491 B-chronic_disease
- 174 175 3491 3492 I-chronic_disease
hypertensive 175 187 3492 3504 I-chronic_disease
agent 188 193 3505 3510 I-chronic_disease

The 0 3 3511 3514 O
last 4 8 3515 3519 O
dose 9 13 3520 3524 O
of 14 16 3525 3527 O
bevacizumab 17 28 3528 3539 B-treatment
must 29 33 3540 3544 O
have 34 38 3545 3549 O
been 39 43 3550 3554 O
administered 44 56 3555 3567 O
at 57 59 3568 3570 O
least 60 65 3571 3576 O
6 66 67 3577 3578 B-lower_bound
weeks 68 73 3579 3584 I-lower_bound
prior 74 79 3585 3590 I-lower_bound
to 80 82 3591 3593 O
liver 83 88 3594 3599 B-treatment
resection 89 98 3600 3609 I-treatment

The 0 3 3610 3613 O
last 4 8 3614 3618 O
dose 9 13 3619 3623 O
of 14 16 3624 3626 O
chemotherapy 17 29 3627 3639 B-treatment
or 30 32 3640 3642 O
radiation 33 42 3643 3652 B-treatment
must 43 47 3653 3657 O
have 48 52 3658 3662 O
been 53 57 3663 3667 O
administered 58 70 3668 3680 O
at 71 73 3681 3683 O
least 74 79 3684 3689 O
4 80 81 3690 3691 B-lower_bound
weeks 82 87 3692 3697 I-lower_bound
prior 88 93 3698 3703 I-lower_bound
to 94 96 3704 3706 O
liver 97 102 3707 3712 B-treatment
surgery 103 110 3713 3720 I-treatment

The 0 3 3721 3724 O
use 4 7 3725 3728 O
of 8 10 3729 3731 O
supplemental 11 23 3732 3744 O
calcium 24 31 3745 3752 O
or 32 34 3753 3755 O
supplements 35 46 3756 3767 O
containing 47 57 3768 3778 O
calcium 58 65 3779 3786 O
is 66 68 3787 3789 O
prohibited 69 79 3790 3800 O
during 80 86 3801 3807 O
the 87 90 3808 3811 O
treatment 91 100 3812 3821 B-treatment
period 101 107 3822 3828 O
of 108 110 3829 3831 O
this 111 115 3832 3836 O
clinical 116 124 3837 3845 B-treatment
trial 125 130 3846 3851 I-treatment

Use 0 3 3852 3855 O
of 4 6 3856 3858 O
supplemental 7 19 3859 3871 O
vitamin 20 27 3872 3879 O
D 28 29 3880 3881 O
or 30 32 3882 3884 O
supplements 33 44 3885 3896 O
containing 45 55 3897 3907 O
vitamin 56 63 3908 3915 O
D 64 65 3916 3917 O
beyond 66 72 3918 3924 O
the 73 76 3925 3928 O
protocol 77 85 3929 3937 O
- 85 86 3937 3938 O
prescribed 86 96 3938 3948 O
study 97 102 3949 3954 B-treatment
treatment 103 112 3955 3964 I-treatment
is 113 115 3965 3967 O
not 116 119 3968 3971 O
allowed 120 127 3972 3979 O
during 128 134 3980 3986 O
the 135 138 3987 3990 O
treatment 139 148 3991 4000 O
period 149 155 4001 4007 O
of 156 158 4008 4010 O
this 159 163 4011 4015 O
clinical 164 172 4016 4024 B-treatment
trial 173 178 4025 4030 I-treatment

Women 0 5 4031 4036 B-gender
of 6 8 4037 4039 O
child 9 14 4040 4045 O
- 14 15 4045 4046 O
bearing 15 22 4046 4053 O
potential 23 32 4054 4063 O
include 33 40 4064 4071 O
any 41 44 4072 4075 O
female 45 51 4076 4082 B-gender
who 52 55 4083 4086 O
has 56 59 4087 4090 O
experienced 60 71 4091 4102 O
menarche 72 80 4103 4111 O
and 81 84 4112 4115 O
who 85 88 4116 4119 O
has 89 92 4120 4123 O
not 93 96 4124 4127 O
undergone 97 106 4128 4137 O
surgical 107 115 4138 4146 B-treatment
sterilization 116 129 4147 4160 I-treatment
( 130 131 4161 4162 O
hysterectomy 131 143 4162 4174 B-treatment
, 143 144 4174 4175 O
bilateral 145 154 4176 4185 B-treatment
tubal 155 160 4186 4191 I-treatment
ligation 161 169 4192 4200 I-treatment
, 169 170 4200 4201 O
or 171 173 4202 4204 O
bilateral 174 183 4205 4214 B-treatment
oophorectomy 184 196 4215 4227 I-treatment
) 196 197 4227 4228 O
or 198 200 4229 4231 O
is 201 203 4232 4234 O
not 204 207 4235 4238 O
postmenopausal 208 222 4239 4253 O
( 223 224 4254 4255 O
defined 224 231 4255 4262 O
as 232 234 4263 4265 O
amenorrhea 235 245 4266 4276 B-clinical_variable
≥12 246 249 4277 4280 O
consecutive 250 261 4281 4292 I-lower_bound
months 262 268 4293 4299 I-lower_bound

Women 0 5 4300 4305 B-gender
of 6 8 4306 4308 O
child 9 14 4309 4314 O
- 14 15 4314 4315 O
bearing 15 22 4315 4322 O
potential 23 32 4323 4332 O
must 33 37 4333 4337 O
have 38 42 4338 4342 O
a 43 44 4343 4344 O
negative 45 53 4345 4353 B-pregnancy
serum 54 59 4354 4359 I-pregnancy
or 60 62 4360 4362 I-pregnancy
urine 63 68 4363 4368 I-pregnancy
pregnancy 69 78 4369 4378 I-pregnancy
test 79 83 4379 4383 O
( 84 85 4384 4385 O
minimum 85 92 4385 4392 O
sensitivity 93 104 4393 4404 O
25 105 107 4405 4407 B-lower_bound
IU 108 110 4408 4410 I-lower_bound
/ 110 111 4410 4411 I-lower_bound
L 111 112 4411 4412 I-lower_bound
or 113 115 4413 4415 O
equivalent 116 126 4416 4426 O
units 127 132 4427 4432 O
of 133 135 4433 4435 O
HCG 136 139 4436 4439 B-clinical_variable
) 139 140 4439 4440 O
within 141 147 4441 4447 O
14 148 150 4448 4450 B-upper_bound
days 151 155 4451 4455 I-upper_bound
prior 156 161 4456 4461 I-upper_bound
to 162 164 4462 4464 O
study 165 170 4465 4470 O
entry 171 176 4471 4476 O

Women 0 5 4477 4482 B-gender
who 6 9 4483 4486 O
are 10 13 4487 4490 O
using 14 19 4491 4496 O
oral 20 24 4497 4501 B-contraception_consent
, 24 25 4501 4502 O
implanted 26 35 4503 4512 B-contraception_consent
, 35 36 4512 4513 O
or 37 39 4514 4516 O
injectable 40 50 4517 4527 B-contraception_consent
contraceptive 51 64 4528 4541 I-contraception_consent
hormones 65 73 4542 4550 I-contraception_consent
or 74 76 4551 4553 O
mechanical 77 87 4554 4564 O
products 88 96 4565 4573 O
such 97 101 4574 4578 O
as 102 104 4579 4581 O
intrauterine 105 117 4582 4594 B-contraception_consent
device 118 124 4595 4601 I-contraception_consent
or 125 127 4602 4604 O
barrier 128 135 4605 4612 B-contraception_consent
methods 136 143 4613 4620 I-contraception_consent
( 144 145 4621 4622 O
diaphragm 145 154 4622 4631 B-contraception_consent
, 154 155 4631 4632 O
condoms 156 163 4633 4640 B-contraception_consent
, 163 164 4640 4641 O
spermicides 165 176 4642 4653 B-contraception_consent
) 176 177 4653 4654 O
to 178 180 4655 4657 O
prevent 181 188 4658 4665 O
pregnancy 189 198 4666 4675 B-pregnancy
, 198 199 4675 4676 O
or 200 202 4677 4679 O
who 203 206 4680 4683 O
are 207 210 4684 4687 O
practicing 211 221 4688 4698 O
abstinence 222 232 4699 4709 O
or 233 235 4710 4712 O
where 236 241 4713 4718 O
partner 242 249 4719 4726 O
is 250 252 4727 4729 O
sterile 253 260 4730 4737 O
( 261 262 4738 4739 O
e.g. 262 266 4739 4743 O
, 266 267 4743 4744 O
vasectomy 268 277 4745 4754 O
) 277 278 4754 4755 O
, 278 279 4755 4756 O
should 280 286 4757 4763 O
be 287 289 4764 4766 O
considered 290 300 4767 4777 O
to 301 303 4778 4780 O
be 304 306 4781 4783 O
of 307 309 4784 4786 O
child 310 315 4787 4792 O
- 315 316 4792 4793 O
bearing 316 323 4793 4800 O
potential 324 333 4801 4810 O

men 0 3 4811 4814 B-gender
/ 3 4 4814 4815 I-gender
women 4 9 4815 4820 I-gender
of 10 12 4821 4823 O
child 13 18 4824 4829 O
- 18 19 4829 4830 O
bearing 19 26 4830 4837 O
potential 27 36 4838 4847 O
who 37 40 4848 4851 O
are 41 44 4852 4855 O
unwilling 45 54 4856 4865 B-contraception_consent
to 55 57 4866 4868 I-contraception_consent
employ 58 64 4869 4875 I-contraception_consent
adequate 65 73 4876 4884 I-contraception_consent
contraception 74 87 4885 4898 I-contraception_consent

nursing 0 7 4899 4906 O
women 8 13 4907 4912 B-gender

women 0 5 4913 4918 B-gender
of 6 8 4919 4921 O
child 9 14 4922 4927 O
- 14 15 4927 4928 O
bearing 15 22 4928 4935 O
potential 23 32 4936 4945 O
and 33 36 4946 4949 O
men 37 40 4950 4953 O
must 41 45 4954 4958 O
agree 46 51 4959 4964 B-contraception_consent
to 52 54 4965 4967 I-contraception_consent
use 55 58 4968 4971 I-contraception_consent
adequate 59 67 4972 4980 I-contraception_consent
contraception 68 81 4981 4994 I-contraception_consent
( 82 83 4995 4996 O
hormonal 83 91 4996 5004 B-contraception_consent
or 92 94 5005 5007 O
barrier 95 102 5008 5015 B-contraception_consent
method 103 109 5016 5022 I-contraception_consent
of 110 112 5023 5025 I-contraception_consent
birth 113 118 5026 5031 I-contraception_consent
control 119 126 5032 5039 I-contraception_consent
; 126 127 5039 5040 O
abstinence 128 138 5041 5051 B-contraception_consent
) 138 139 5051 5052 O
prior 140 145 5053 5058 O
to 146 148 5059 5061 O
study 149 154 5062 5067 O
entry 155 160 5068 5073 O
and 161 164 5074 5077 O
for 165 168 5078 5081 O
the 169 172 5082 5085 O
duration 173 181 5086 5094 O
of 182 184 5095 5097 O
study 185 190 5098 5103 O
participation 191 204 5104 5117 O

women 0 5 5118 5123 B-gender
on 6 8 5124 5126 O
hormone 9 16 5127 5134 B-treatment
replacement 17 28 5135 5146 I-treatment
therapy 29 36 5147 5154 I-treatment
with 37 41 5155 5159 O
documented 42 52 5160 5170 O
serum 53 58 5171 5176 B-clinical_variable
follicle 59 67 5177 5185 I-clinical_variable
stimulating 68 79 5186 5197 I-clinical_variable
hormone 80 87 5198 5205 I-clinical_variable
level 88 93 5206 5211 I-clinical_variable
> 94 95 5212 5213 O
35 95 97 5213 5215 B-lower_bound
mIU 98 101 5216 5219 I-lower_bound
/ 101 102 5219 5220 I-lower_bound
mL 102 104 5220 5222 I-lower_bound
) 104 105 5222 5223 O

